Marijuana Stocks Surge on Potential Federal Reclassification
Cannabis-related equities experienced dramatic gains Friday amid reports that President TRUMP may soon reclassify marijuana under federal drug laws. Tilray Brands (TLRY) soared nearly 30% while Canopy Growth (CGC) jumped 40% in intraday trading.
The potential executive order WOULD shift marijuana from Schedule I (alongside heroin) to Schedule III (with steroids and codeine), significantly reducing regulatory burdens. This comes despite ongoing federal prohibition, even as 38 states have legalized medical or recreational use.
Market participants are pricing in improved access to banking services and capital markets for cannabis firms. The WHITE House confirmed no final decision has been made, with conflicting reports about timing from CNBC (potential Monday action) versus Axios (2025 implementation).